| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/08/2008 | WO2008053331A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| 05/08/2008 | WO2008052322A1 Immunotoxγn fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 05/08/2008 | WO2008028116A3 Method and composition to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test |
| 05/08/2008 | WO2008015415A3 Asymmetric fluoro-substituted polymethine dyes |
| 05/08/2008 | WO2007141767A3 Elimination of contrast agent concentration dependency in mri |
| 05/08/2008 | WO2007049061A3 Conjugates of semaphorin peptides as imaging agents for cancer |
| 05/08/2008 | US20080108711 Use of the Slug Gene or the Replication, Transcription or Expression Products Thereof in the Identification, Diagnosis, Prevention or Treatment of the Spread of Cancer and/or the Development of Metastasis |
| 05/08/2008 | US20080107709 Radio-opaque polymeric biomaterials |
| 05/08/2008 | US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development |
| 05/08/2008 | US20080107674 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/08/2008 | US20080107607 Peptide-phospholipid conjugate;ultrasound contrast agent compositions; imaging KDR-containing tissue, evaluating angiogenic processes associated with neoplastic conditions |
| 05/08/2008 | US20080107606 Bifunctional chelators for sequestering lanthanides |
| 05/08/2008 | US20080107604 Method for the Prediction of the Risk Potential for Cancerous Diseases and Inflammatory Intestinal Diseases and Corresponding Tests |
| 05/08/2008 | US20080107601 Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's Disease |
| 05/08/2008 | US20080107598 Conjugating a chelator, ethylenedicysteine to a targeting ligand, glucosamine, deoxyglucose, metronidazole, annexin V, guanine or LHRH; and a metal ion of 99mTc, 68Ga, 188Re or 187Re |
| 05/08/2008 | US20080107596 Breast cancer specific genes; a polynucleotide, a protein expressed by a polynucleotide, a polynucleotide capable of hybridizing under stringent conditions |
| 05/08/2008 | CA2668017A1 Improved conjugates |
| 05/08/2008 | CA2667211A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
| 05/08/2008 | CA2649294A1 Methods for assessing cell labeling |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1774028A4 Methods and compositions for treating obesity |
| 05/07/2008 | EP1711618A4 Methods for detecting markers associated with endometrial disease or phase |
| 05/07/2008 | EP0920495B1 Transgenic animal model for alzheimer disease |
| 05/07/2008 | CN100386057C System and method of perfusion imaging and ultrasonic control releasing based-on capsule microbubble |
| 05/06/2008 | US7368474 [18F]-fluorination for use making radiopharmaceuticals for Positron Emission Tomography (PET); reacting a compound of formula 18F-(Linker)-SH with an activated peptide |
| 05/06/2008 | US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same |
| 05/06/2008 | US7368261 Conserved Neisserial antigens |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368109 For ameliorating acquired immunodeficiency syndrome (AIDS), an antoimmune disease, or graft rejection |
| 05/06/2008 | US7368101 Process for the preparation of iopamidol and the new intermediates therein |
| 05/06/2008 | US7368099 MRI contrast agents |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | US7367934 Methods of enhancing radiation effects with metal nanoparticles |
| 05/06/2008 | CA2286668C Trans-platinum compound, and diagnostic kit |
| 05/02/2008 | WO2008052136A2 Controlled activation ingestible identifier |
| 05/02/2008 | WO2008051291A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| 05/02/2008 | WO2008050255A2 Contrast agents for detecting prostate cancer |
| 05/02/2008 | WO2008049644A1 Thymidine analogs for imaging |
| 05/02/2008 | WO2008049239A1 Endometrial biomarkers |
| 05/02/2008 | WO2007095443A3 Gastrin releasing peptide compounds |
| 05/02/2008 | WO2006121889A3 Chemical exchange saturation transfer contrast agents |
| 05/02/2008 | WO2005084329A8 Method for inhibiting tumor formation and growth |
| 05/02/2008 | CA2703795A1 Endometrial phase or endometrial cancer biomarkers |
| 05/01/2008 | US20080102036 Biocompatible Fluorescent Silicon Nanoparticles |
| 05/01/2008 | US20080102035 Medical device having discrete regions |
| 05/01/2008 | US20080102034 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102033 Antihyperplastic agent preparation applicable to angiography catheter; enhancing artery and/or vein imaging; side effect reduction; rapid, efficient absorption through capillary walls |
| 05/01/2008 | US20080102032 Methods of Treating Diabetes Using Inhibitors of ARNT2 |
| 05/01/2008 | US20080102030 Particles for cell targeting |
| 05/01/2008 | US20080102029 Loadable Polymeric Particles For Enhanced Imaging In Clinical Applications And Methods Of Preparing And Using The Same |
| 05/01/2008 | US20080102027 Targer For B-Cell Disorders |
| 04/30/2008 | EP1916003A1 Thymidine analogs for imaging |
| 04/30/2008 | EP1915423A2 Silylamine modified nanoparticulate carriers |
| 04/30/2008 | EP1307486B1 Somatostatin analogues |
| 04/30/2008 | CN101171337A Methods and composition related to in vivo imaging of gene expression |
| 04/30/2008 | CN101168066A Method for making animal model simulated human cornea fungal infection |
| 04/30/2008 | CN101167887A Orally-administered matrimony vine single preparation traditional Chinese medicine for treating diabetes and preparation method thereof |
| 04/30/2008 | CN100384875C 蛋白质 Protein |
| 04/30/2008 | CN100384482C Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 04/29/2008 | US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/29/2008 | US7365047 Injecting pentagastrin and a gastrin, with gastric proton pump inhibitor effective to reduce gastric acid secretion |
| 04/29/2008 | US7364889 Catalytically active peptides |
| 04/29/2008 | US7364719 Vasoregulating compounds and methods of their use |
| 04/29/2008 | CA2280133C Method for detecting abnormal epithelial cell shedding |
| 04/29/2008 | CA2250485C Diagnostic agent for diabetes |
| 04/29/2008 | CA2246779C Improvements in or relating to contrast agents |
| 04/29/2008 | CA2177952C Nucleosides and oligonucleotides containing boron clusters |
| 04/29/2008 | CA2164845C Methods of preparing gas and gaseous precursor-filled microspheres |
| 04/24/2008 | WO2008048322A1 Mouse models to study cachexia |
| 04/24/2008 | WO2008048288A2 Novel nanoparticles and use thereof |
| 04/24/2008 | WO2008048271A2 Polymer coated microparticles |
| 04/24/2008 | WO2008048074A1 Use of core-shell gold nanoparticle which contains magnetic nanoparticles for mri t2 contrast agent, cancer diagnostic and therapy |
| 04/24/2008 | WO2008047548A1 Metal-containing fine particle |
| 04/24/2008 | WO2008047345A1 Dendrimeric platform for controlled release of drugs |
| 04/24/2008 | WO2008046463A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
| 04/24/2008 | WO2008020765A3 Imaging medium comprising lactate and hyperpolarised 13c-pyruvate |
| 04/24/2008 | WO2007111515A3 Method to produce hyperpolarised carboxylates and sulphonates |
| 04/24/2008 | US20080095716 A sterile and nonflammable mixture of carbon dioxide and oxygen suitable for producing microbubbles in a foaming liquid containing a sclerosing agent; contrast agents for ultrasounds; side effect reduction; nontoxic |
| 04/24/2008 | US20080095715 Cyclic nonapeptides coupled to a cyanine dye as an imaging contrast agent; monitoring angiogenesis inhibition |
| 04/24/2008 | US20080095714 Administering metallic nanoparticles to localize in macrophages to overcome the cooling effect of blood flow on the plaque, heating such nanoparticles with a pulsed laser, and imaging the temperature differences; ultrasound or optical coherence tomography imaging systems; atherosclerosis; diagnosis |
| 04/24/2008 | US20080095713 Administering hyperpolarized C-13 pyruvate to a patient, acquiring carbon-13 magnetic resonance images of pyruvate and its metabolites alanine and lactate, correcting the lactate signal; high lactate signal indicates tumors; improved early stage detection |
| 04/24/2008 | US20080095712 Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in living organisms |
| 04/24/2008 | US20080095710 Enzyme treatment of foodstuffs for celiac sprue |
| 04/24/2008 | US20080095709 Method and apparatus for installation of dental implant |
| 04/24/2008 | US20080095708 Biphenyl compounds useful as muscarinic receptor antagonists |
| 04/24/2008 | US20080095707 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents |
| 04/24/2008 | US20080095706 Detecting binding between the peptide probe and any target protein present in the specific state of self-aggregation,to identify or treat diseases associated with conformationally-altered proteins; medical diagnosis; target protein selectedamyloid islet polypeptide precursor protein, insulin, amylin |
| 04/24/2008 | US20080095705 Methods and Devices for Facile Fabrication of Nanoparticles and Their Applications |
| 04/24/2008 | US20080095704 A polyoxyethylene glycol having a molecular weight of < 3000 Da and 2-50 ethylene glycol units, an imageable moiety anda non-peptidic vector moiety provided that the vector does not have affinity for the Angiotensin II receptor; enhanced contrast; tomography (SPECT); PET sccans; MRIs |
| 04/24/2008 | US20080095703 Method For Checking And Controlling The Mammalian Lactic Acid Fermentation Process / Aerobic Glucose Fermentation Metabolic Pathway In Mammalian Organism |
| 04/24/2008 | US20080095699 Imaging contrast agents using nanoparticles |
| 04/24/2008 | DE102006049821A1 New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues |
| 04/24/2008 | CA2666910A1 Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use |
| 04/24/2008 | CA2666843A1 Treatment of age-related macular degeneration and other diseases of the eye |
| 04/23/2008 | EP1914651A1 Systems and methods for managing information relating to medical fluids and containers therefor |
| 04/23/2008 | EP1914316A2 Microorganisms and cells for diagnosis and therapy of tumors |
| 04/23/2008 | EP1912561A2 Method for determining redox status of a tissue |
| 04/23/2008 | EP1687441B1 Means and methods for the determination of camp in vitro |
| 04/23/2008 | CN201049078Y Rapid air-filling device for digestive canal disease diagnosis and treatment |